- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4046EUR$4,490USD£3,469GBP
- Report
- January 2026
- 186 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- May 2026
- 180 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- May 2026
- 185 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- May 2026
- 185 Pages
Global
From €4055EUR$4,500USD£3,477GBP
- Report
- July 2026
- 120 Pages
Global
From €4280EUR$4,750USD£3,670GBP
- Report
- July 2026
- 116 Pages
Global
From €4280EUR$4,750USD£3,670GBP
- Report
- May 2026
- 350 Pages
Global
From €4459EUR$4,949USD£3,824GBP
- Report
- January 2026
- 286 Pages
Global
From €2253EUR$2,500USD£1,932GBP
- Report
- April 2026
- 142 Pages
Global
From €2702EUR$2,999USD£2,317GBP
€3603EUR$3,999USD£3,090GBP
- Report
- June 2026
- 135 Pages
Global
From €2702EUR$2,999USD£2,317GBP
€3603EUR$3,999USD£3,090GBP
- Report
- April 2026
- 147 Pages
Global
From €2702EUR$2,999USD£2,317GBP
€3603EUR$3,999USD£3,090GBP
- Report
- August 2026
- 160 Pages
Global
From €4280EUR$4,750USD£3,670GBP
- Report
- July 2026
- 180 Pages
Global
From €4280EUR$4,750USD£3,670GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more